Skip to main content
. 2017 Nov 22;12(12):1700070. doi: 10.1002/biot.201700070

Table 1.

Products used in cartilage tissue engineering that have either European Medicines Agency (EMA) or Food and Drug Administration (FDA) approval

Trade name Marketing company Product components Regenerative triad elements Approval authority Date of approval
Polyethylene glycol (PEG) Scaffold FDA Pre 2010
Polylactic acid (PLA) Scaffold FDA Pre 2010
Polylactide‐glycolic acid (PLGA) Scaffold FDA Pre 2010
Carticel® Vericel Autologous chondrocytes Cells FDA Pre 2010
SaluCartilage™ Salumedica Poly‐vinyl alcohol (PVA) hydrogel Scaffold EMA, FDA Pre 2010
CaReS® Arthrokinetics Autologous chondrocytes and type 1 collagen Cells and scaffold EMA Pre 2010
MACI® Vericel Autologous chondrocytes and porcine collagen Cells and scaffold FDA Post 2010
BST‐Cargel® Smith & Nephew Chitosan polysaccharide Liquid scaffold EMA Post 2010
GelrinC Reagentis Biomaterials Polyethylene glycol diacrylate (PEG‐DA) and denatured fibrinogen, crosslinked with UVA light Scaffold EMA Post 2010
Agili‐C™ CartiHeal Aragonite and hyaluronic acid Biphasic scaffold EMA Post 2010